Keros Therapeutics Inc (KROS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KROS | CGON | AKRO | ||
| Company | Keros Therapeutics Inc | Cg Oncology Inc | Akero Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 53.35 | 32.26 | 31.55 | ||
| High | 57.33 | 33.71 | 32.38 | ||
| Low | 53.06 | 32.26 | 31.05 | ||
| Last | 57.03 | 33.55 | 32.33 | ||
| Change | +3.19 | +1.21 | +1.13 | ||
| % Change | +5.92% | +3.74% | +3.62% | ||
| Volume | 142,814 | 178,432 | 328,641 | ||
| 20-Day Average Volume | 416,844 | 431,818 | 687,621 | ||
| Previous Close | 53.84 | 32.34 | 31.20 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 60.43 | 35.84 | 31.67 | ||
| 20-Day Raw Stochastic | 26.64% | 22.52% | 57.66% | ||
| 20-Day Relative Strength | 47.32% | 42.40% | 55.12% | ||
| Weighted Alpha | +60.54 | -7.17 | +83.82 | ||
| Today's Opinion | 40% Buy | 40% Sell | 88% Buy | ||
| Previous Opinion | 24% Buy | 40% Sell | 72% Buy | ||
| Last Month's Opinion | 56% Buy | 24% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.25% since 11/15/24 | +1.38% since 11/15/24 | +14.41% since 11/15/24 | ||
| Low | 52.63 on 11/20/24 | 31.28 on 11/21/24 | 28.44 on 11/18/24 | ||
| High | 57.33 on 11/22/24 | 34.10 on 11/18/24 | 32.22 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | -3.37% since 10/22/24 | -9.82% since 10/22/24 | +8.61% since 10/22/24 | ||
| Low | 52.63 on 11/20/24 | 31.28 on 11/21/24 | 27.05 on 11/15/24 | ||
| High | 70.26 on 11/11/24 | 40.47 on 11/11/24 | 35.88 on 11/07/24 | ||
| 3-Month | |||||
| %Chg | +28.14% since 08/22/24 | -7.18% since 08/22/24 | +23.09% since 08/22/24 | ||
| Low | 44.45 on 08/23/24 | 31.28 on 11/21/24 | 25.01 on 09/11/24 | ||
| High | 70.26 on 11/11/24 | 40.47 on 11/11/24 | 35.88 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | +12.17% since 05/22/24 | +8.24% since 05/22/24 | +56.77% since 05/22/24 | ||
| Low | 40.93 on 07/09/24 | 29.00 on 08/05/24 | 17.86 on 06/05/24 | ||
| High | 70.26 on 11/11/24 | 40.47 on 11/11/24 | 35.88 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,180,896 | 2,187,154 | 2,177,729 | ||
| Shares Outstanding, K | 40,507 | 67,630 | 69,799 | ||
| Annual Sales | 150,000 | 200,000 | 0 | ||
| Annual Net Income | -152,990,000 | -48,610,000 | -151,760,000 | ||
| Last Quarter Sales | 390,000 | 40,000 | 0 | ||
| Last Quarter Net Income | -52,960,000 | -20,410,000 | -72,710,000 | ||
| 60-Month Beta | 1.23 | N/A | -0.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.41 on 11/06/24 | -0.30 on 11/12/24 | -1.05 on 11/08/24 | ||
| Latest Earnings Date | 11/04/24 | 11/14/24 | 11/11/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||